239 related articles for article (PubMed ID: 34079064)
1. Claudin-2 promotes colorectal cancer liver metastasis and is a biomarker of the replacement type growth pattern.
Tabariès S; Annis MG; Lazaris A; Petrillo SK; Huxham J; Abdellatif A; Palmieri V; Chabot J; Johnson RM; Van Laere S; Verhoef C; Hachem Y; Yumeen S; Meti N; Omeroglu A; Altinel G; Gao ZH; Yu ASL; Grünhagen DJ; Vermeulen P; Metrakos P; Siegel PM
Commun Biol; 2021 Jun; 4(1):657. PubMed ID: 34079064
[TBL] [Abstract][Full Text] [Related]
2. Afadin cooperates with Claudin-2 to promote breast cancer metastasis.
Tabariès S; McNulty A; Ouellet V; Annis MG; Dessureault M; Vinette M; Hachem Y; Lavoie B; Omeroglu A; Simon HG; Walsh LA; Kimbung S; Hedenfalk I; Siegel PM
Genes Dev; 2019 Feb; 33(3-4):180-193. PubMed ID: 30692208
[TBL] [Abstract][Full Text] [Related]
3. Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
Tabariès S; Annis MG; Hsu BE; Tam CE; Savage P; Park M; Siegel PM
Oncotarget; 2015 Apr; 6(11):9476-87. PubMed ID: 25823815
[TBL] [Abstract][Full Text] [Related]
4. Sequential biphasic changes in claudin1 and claudin4 expression are correlated to colorectal cancer progression and liver metastasis.
Georges R; Bergmann F; Hamdi H; Zepp M; Eyol E; Hielscher T; Berger MR; Adwan H
J Cell Mol Med; 2012 Feb; 16(2):260-72. PubMed ID: 21388515
[TBL] [Abstract][Full Text] [Related]
5. Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes.
Tabariès S; Dupuy F; Dong Z; Monast A; Annis MG; Spicer J; Ferri LE; Omeroglu A; Basik M; Amir E; Clemons M; Siegel PM
Mol Cell Biol; 2012 Aug; 32(15):2979-91. PubMed ID: 22645303
[TBL] [Abstract][Full Text] [Related]
6. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
[TBL] [Abstract][Full Text] [Related]
7. [Claudins as prognostic factors of breast cancer].
Szász MA
Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
[TBL] [Abstract][Full Text] [Related]
8. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
[TBL] [Abstract][Full Text] [Related]
9. Distinct claudin expression profiles of hepatocellular carcinoma and metastatic colorectal and pancreatic carcinomas.
Holczbauer Á; Gyöngyösi B; Lotz G; Szijártó A; Kupcsulik P; Schaff Z; Kiss A
J Histochem Cytochem; 2013 Apr; 61(4):294-305. PubMed ID: 23385421
[TBL] [Abstract][Full Text] [Related]
10. Tissue inhibitor of matrix metalloproteinase-1 expression in colorectal cancer liver metastases is associated with vascular structures.
Illemann M; Eefsen RH; Bird NC; Majeed A; Osterlind K; Laerum OD; Alpízar-Alpízar W; Lund IK; Høyer-Hansen G
Mol Carcinog; 2016 Feb; 55(2):193-208. PubMed ID: 25594187
[TBL] [Abstract][Full Text] [Related]
11. A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients.
Gowrikumar S; Primeaux M; Pravoverov K; Wu C; Szeglin BC; Sauvé CG; Thapa I; Bastola D; Chen XS; Smith JJ; Singh AB; Dhawan P
Cells; 2021 Aug; 10(9):. PubMed ID: 34571860
[TBL] [Abstract][Full Text] [Related]
12. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis.
Huang X; Sheng Y; Guan M
Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578
[TBL] [Abstract][Full Text] [Related]
13. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases.
Kato H; Semba S; Miskad UA; Seo Y; Kasuga M; Yokozaki H
Clin Cancer Res; 2004 Nov; 10(21):7318-28. PubMed ID: 15534108
[TBL] [Abstract][Full Text] [Related]
14. Anti-Claudin-2 Antibody-Drug Conjugates for the Treatment of Colorectal Cancer Liver Metastasis.
Tabariès S; Robert A; Marcil A; Ling B; Acchione M; Lippens J; Pagé M; Fortin A; Meury L; Coutu M; Annis MG; Girondel C; Navarre J; Jaramillo M; Moraitis AN; Siegel PM
Mol Cancer Ther; 2024 Jun; ():. PubMed ID: 38902871
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
Wang D; Fu L; Sun H; Guo L; DuBois RN
Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
[TBL] [Abstract][Full Text] [Related]
16. Stromal cell derived factor-1 and CXCR4 expression in colorectal cancer promote liver metastasis.
Amara S; Chaar I; Khiari M; Ounissi D; Weslati M; Boughriba R; Hmida AB; Bouraoui S
Cancer Biomark; 2015; 15(6):869-79. PubMed ID: 26406413
[TBL] [Abstract][Full Text] [Related]
17. Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer.
Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
Oncol Rep; 2008 Apr; 19(4):953-9. PubMed ID: 18357381
[TBL] [Abstract][Full Text] [Related]
18. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
19. Claudin-7 promotes the epithelial-mesenchymal transition in human colorectal cancer.
Philip R; Heiler S; Mu W; Büchler MW; Zöller M; Thuma F
Oncotarget; 2015 Feb; 6(4):2046-63. PubMed ID: 25514462
[TBL] [Abstract][Full Text] [Related]
20. Dual-specificity tyrosine-regulated kinase 2 is a suppressor and potential prognostic marker for liver metastasis of colorectal cancer.
Ito D; Yogosawa S; Mimoto R; Hirooka S; Horiuchi T; Eto K; Yanaga K; Yoshida K
Cancer Sci; 2017 Aug; 108(8):1565-1573. PubMed ID: 28502078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
